IP Verse

Rodent Capable Of Producing Hybrid Antibodies Containing Human Variable Regions And Rodent Constant Regions

Patent No. EP2787075 (titled "Rodent Capable Of Producing Hybrid Antibodies Containing Human Variable Regions And Rodent Constant Regions") was filed by Regeneron Pharmaceuticals on Feb 15, 2002. The application was issued on Oct 18, 2023.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
MERUSAug 30, 2017LAHRTZ
NOVO NORDISKAug 29, 2017POTTER CLARKSON
KYMABJul 11, 2017CMS CAMERON MCKENNA NABARRO OLSWANG

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP2787075

REGENERON PHARMACEUTICALS
Application Number
EP14172420A
Filing Date
Feb 15, 2002
Status
Patent Maintained As Amended
Sep 15, 2023
Publication Date
Oct 18, 2023
External Links
Slate, Register , Google Patents